Referensi
Centers for Disease Control and Prevention, “Clinical Overview of Shingles (Herpes Zoster),” diakses 9 November 2026.
Centers for Disease Control and Prevention, “Clinical Overview of Shingles (Herpes Zoster),” diakses 9 November 2026.
Abda Mahmood, Marie Nishimwe, Yasmeeta Vekria, Karabo Keapoletswe, Sarah Lay-Flurrie, Spyros Paparrodopoulos, Simeon Stavrev, et al., “Herpes Zoster Incidence Rates in Adults Aged 18 Years or Older with Immunocompromising or Chronic Conditions in England: A Large Retrospective Cohort Study (Clinical Practice Research Datalink, 2012–2019),” BMJ Open 16, no. 9 (2026): e114923, https://doi.org/10.1136/bmjopen-2025-114923.
Maren Steinmann, David Lampe, John Grosser, Juliana Schmidt, Marla Louise Hohoff, Anita Fischer, and Wolfgang Greiner, “Risk Factors for Herpes Zoster Infections: A Systematic Review and Meta-Analysis Unveiling Common Trends and Heterogeneity Patterns,” Infection 52, no. 3 (2024): 1009–26, https://doi.org/10.1007/s15010-023-02156-y.
Viorica Ileana Bumbea, Horia Bumbea, and Ana Maria Vladareanu, “Immune Dysfunction in Patients with End Stage Kidney Disease; Immunosenescence—Review,” Romanian Journal of Internal Medicine 62, no. 1 (2024): 12–19, https://doi.org/10.2478/rjim-2023-0030.
Kei Sakurabayashi, Masaki Muramatsu, Yoshihiro Itabashi, et al., “Survey of Herpes Zoster in Kidney Transplant Patients: A Single-Center Study,” International Journal of Urology 33, no. 2 (2026): e70388, https://doi.org/10.1111/iju.70388.
Centers for Disease Control and Prevention, “Shingles Symptoms and Complications,” diakses 9 November 2026.
Centers for Disease Control and Prevention, “Clinical Overview of Shingles (Herpes Zoster),” diakses 9 November 2026.
National Library of Medicine, “Valacyclovir Tablet: Prescribing Information,” DailyMed, diakses 9 November 2026.
Centers for Disease Control and Prevention, “Clinical Considerations for Shingrix Use in Immunocompromised Adults Aged ≥19 Years,” diakses 9 November 2026.